StockDuty ← Dashboard Sep 25, 2026 04:27 PM ET
CatalystFDA/Bio

ADARX PHARMACEUTICALS RAISED $446 MILLION IN A BIOTECH IPO BACKED BY ABBVIE - QZ

ADARX raised $446 million in a biotech IPO backed by AbbVie.

What changed
ADARX raised $446 million in a biotech IPO backed by AbbVie.
Why it matters
ADARX raised $446 million in a biotech IPO backed by AbbVie. — impact context not separately stored; see What changed.
Sources
qz
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →